20412 ⎘
Medicinal preparations containing organic active ingredients; Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two nitrogen atoms as the only ring heteroatoms, e.g. piperazine Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-α]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof
#902SHP1 AND SHP2 INHIBITORS AND THEIR METHODS OF USE
#903Liquid oral formulations for tadalafil
#904ORGANIC COMPOUNDS
#905STEREOISOMERS OF THE COMPOUND 3-(BENZO[D][1,3]DIOXOL-5-YL)-7-(1-HYDROXYPROPAN-2-YL)-1-(1H-INDOL-3-YL)-6,7-DIHYDRO-3H-OXAZOL[3,4-A]PYRAZINE-5,8-DIONE AND USE THEREOF AS AN ANTITUMOR AGENT AND PHOSPHODIESTERASE ENZYME INHIBITOR
#906Metformin glycinate, pharmaceutical compositions comprising the same, and methods of using the same
#907SHP2 INHIBITORS
#908METHODS OF TREATING A SUBJECT WITH A CDC42-SPECIFIC INHIBITOR
#909COMPOSITIONS AND METHODS FOR TREATING HEMORRHAGIC STROKE
#910METHOD OF TREATING NEOPLASTIC DISEASES WITH A CDC42-SPECIFIC INHIBITOR
#911PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2-TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF
#912HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF ARENAVIRUS INFECTION
#913PHARMACEUTICAL COMPOSITION FOR TREATING AFRICAN SWINE FEVER AND USE THEREOF
#914USES OF 5-METHYLTETRAHYDROFOLATE AND ITS COMPOSITION
#915Methods of treating crohn's disease and ulcerative colitis
#916TREATMENT OF CANCER WITH TOR KINASE INHIBITORS
#917COMPOSITIONS AND METHODS FOR TREATMENT OF PRESBYOPIA
#918Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof
#919DOSAGE FORM COMPOSITIONS COMPRISING AN INHIBITOR OF BRUTON'S TYROSINE KINASE
#920COMBINATION THERAPY OF GPR119 AGONISTS AND DPP-4 INHIBITORS
#921BILE ACID RECYCLING INHIBITORS FOR TREATMENT OF PEDIATRIC CHOLESTATIC LIVER DISEASES
#922Bromocriptine formulations
#923COMBINATION FOR THE TREATMENT OF INFECTIONS CAUSED BY MYCOPLASMA GENITALIUM
#924Treatment of a disease of the gastrointestinal tract with a JAK or other kinase inhibitor
#925ANTI-PD-L1 COMBINATIONS FOR TREATING TUMORS
#926PAC1 receptor agonists (MAXCAPs) and uses thereof
#927Nitrogen-containing condensed ring compounds having dopamine D3 antagonistic effect
#928Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof
#929METHOD FOR TREATING CANCER USING A COMBINATION OF CHK1 AND ATR INHIBITORS
#930COMPOUNDS AND METHOD FOR TREATING CYTOKINE RELEASE SYNDROME
#931A NOVEL THERAPY FOR ERYTHROPOIETIC PROTOPORPHYRIA (EPP) AND X-LINKED PROTOPORPHYRIA (XLP)
#932Administration of antipsychotics
#933UNIT DOSAGE FORM FOR TRANSMUCOSAL DRUG DELIVERY OF AN ACTIVE PHARMACEUTICAL INGREDIENT
#934Pulmonary hypertension treatment
#935COMPOSITIONS AND METHODS FOR TREATING CANCER
#936COMBINATIONS OF INHIBITORS OF IRAK4 WITH INHIBITORS OF BTK
#937METHODS USING HDAC11 INHIBITORS
#938Adenosine derivative and pharmaceutical composition comprising the same
#939METHOD FOR ALPHAVIRUS INHIBITION
#940Compositions and use of varenicline for treating dry eye
#941Methods of treating Crohn's disease and ulcerative colitis
#942COMBINATION OF HEPATITIS B VIRUS (HBV) VACCINES AND DIHYDROPYRIMIDINE DERIVATIVES AS CAPSID ASSEMBLY MODULATORS
#943Substituted pyrido[1,2-a]pyrrolo[1,2-d]pyrazines for treating viral infections
#944COMPOUND USED AS RET KINASE INHIBITOR AND APPLICATION THEREOF
#945COMPOSITIONS AND METHODS FOR TREATING SCHISTOSOMA INFECTIONS
#946Phosphodiesterase Inhibitor Treatment
#947INTEGRATION OF MOLECULAR MECHANISMS IN THE STRIATUM AS A COMBINATION DRUG STRATEGY FOR THE TREATMENT OF PSYCHIATRIC AND NEUROLOGICAL DISORDERS IN WHICH ANHEDONIA OR MOTIVATION-RELATED DYSFUNCTION EXISTS
#948SYNERGISTIC COMBINATIONS AND METHODS OF USE
#949SYNERGISTIC COMBINATIONS AND METHODS OF USE
#950SYNERGISTIC COMBINATIONS AND METHODS OF USE
#951Parenteral unit dosage form of dihydroergotamine
#952COMBINATION PRODUCT CONTAINING LIMONOID COMPOUND AND DPP-4 INHIBITOR
#953SUBSTITUTED 1,2,3,3a,4,5,7,9,13,13a-DECAHYDROPYRIDO[1',2':4,5]PYRAZINO[1,2-a]PYRROLO[1,2-c]PYRIMIDINES HAVING HIV INTEGRASE INHIBITORY ACTIVITY
#954Inhibitors of Bruton's Tyrosine Kinase
#955Endoparasitic depsipeptides
#956Methods and Compositions for Treating Cancer
#957INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION
#958Compounds and methods for treating cancer
#959Agent for use in the treatment of glioma
#960Amorphous solid dispersions
#961COMPOSITIONS AND METHODS FOR THE TREATMENT OF ADDICTION AND OTHER NEUROPSYCHIATRIC DISORDERS
#962METHOD OF TREATING KELOIDS
#963Method of treating fibrosis
#964COMBINATION OF ENZASTAURIN AND INHIBITORS OF BTK AND USES THEREOF
#965Uses of DPP IV inhibitors
#966METHODS OF TREATING NEUROPATHIC PAIN
#967GEPOTIDACIN FOR USE IN THE TREATMENT OF BACTERIAL URINARY TRACT INFECTIONS
#968LOW-DOSE TRIPLE COMBINATION FORMULATION
#969Methods of treating splenomegaly
#970Crystal Forms of (S)-4-(8-amino-3-(1-(but-2-ynoyl)-pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-n-(pyridin-2-yl)benzamide
#971Sulfoximine glycosidase inhibitors
#972Inhibition of Monoamine Oxidase Subtype A (MAOA) Mitigates Cardiovascular Calcification
#973TREATMENT OF HEPATOCELLULAR CARCINOMA CHARACTERIZED BY HEPATITIS B VIRUS INFECTION
#974METHODS FOR TREATING ALZHEIMER DISEASE AND FOR REDUCING AMYLOID BETA FORMATION
#975TREATMENT OF RAYNAUD'S DISEASE
#976SMALL-MOLECULE INHIBITOR OF PD-1/PD-L1, PHARMACEUTICAL COMPOSITION THEREOF WITH PD-L1 ANTIBODY, AND APPLICATION OF SAME
#977METHODS FOR CONTROLLING PROSTAGLANDIN-MEDIATED BIOLOGICAL PROCESSES
#978Compounds and pharmaceutical uses thereof
#979TARGETING LASP1, EIF4A1, EIF4B AND CXC4 WITH MODULATORS AND COMBINATIONS THEREOF FOR CANCER THERAPY
#980SOLIDIFICATION OR CRYSTALLISATION METHOD
#981PDE5 inhibitor powder formulations and methods relating thereto
#982Methods of treatment using pharmaceutical capsule compositions comprising lumateperone mono-tosylate
#983Praziquantel Formulations
#984TUNABLE ENDOGENOUS PROTEIN DEGRADATION
#985PHARMACEUTICAL FORMULATIONS, PROCESSES FOR PREPARATION, AND METHODS OF USE
#986RABEXIMOD IN THE TREATMENT OF RHEUMATOID ARTHRITIS
#987COMPOUNDS FOR PREVENTING, INHIBITING, OR TREATING CANCER, AIDS AND/OR PREMATURE AGING
#988LIPID PRODRUGS OF JAK INHIBITORS AND USES THEREOF
#989Compounds and compositions for treating conditions associated with APJ receptor activity
#990SUBSTITUTED BENZALDEHYDE COMPOUNDS AND METHODS FOR THEIR USE IN INCREASING TISSUE OXYGENATION
#9912-(3′-(hydroxymethyl)-1-methyl-5-((5-(2-methyl-4-(oxetan-3-yl)piperazin-1-yl)pyridin-2-yl)amino)-6-oxo-1,6-dihydro-[3,4′-bipyridin]-2′-yl)-7,7-dimethyl-7,8-dihydro-2H-cyclopenta[4,5]pyrrolo[1,2-a]pyrazin-1(6H)-one as a BTK inhibitor
#992SUBSTITUTED TETRAHYDROQUINOLINONE COMPOUNDS AS ROR GAMMA MODULATORS
#993METHOD OF PREVENTING OR TREATING TREATMENT-INDUCED GASTROINTESTINAL INJURY
#994PHARMACEUTICAL COMPOSITION
#995Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both naturally occurring tumor immunity and immunotherapy
#996LIQUID PHARMACEUTICAL COMPOSITIONS
#997Combination Products to Mitigate the Risk of Non-Benzodiazepine Benzodiazepine Agonist Adverse Reaction and Overdose
#998METHODS OF TREATING DISEASE WITH MAGL INHIBITORS
#999INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION
#1000FUSED TRICYCLIC PYRAZOLO-DIHYDROPYRAZINYL-PYRIDONE COMPOUNDS AS ANTIVIRALS
#1001COMBINATION DRUG THERAPIES OF PDE-5 INHIBITORS AND INHALED NITRIC OXIDE
#1002Pharmaceutical composition for the treatment of pulmonary arterial hypertension
#1003PHARMACEUTICAL COMPOSITIONS
#1004Anti-EGFR combinations for treating tumors
#1005LINEAR POLYSACCHARIDE BASED FILM PRODUCTS
#1006Therapeutic regimen
#1007METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF AGE-RELATED CARDIOMETABOLIC DISEASES
#1008METHODS OF TREATING ADDICTION
#1009Therapeutic combinations of a BTK inhibitor, a PI3K inhibitor, a JAK-2 inhibitor, and/or a BCL-2 inhibitor
#1010PREVENTION OF ANESTHETIC-INDUCED NEUROCOGNITIVE DYSFUNCTION
#1011Antidiabetic pharmaceutical compositions and preparation method thereof
#1012INHIBITORS OF JUN N-TERMINAL KINASE
#1013COMPOSITION FOR PREVENTING OR TREATING LIVER DISEASES
#1014Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof
#1015EXTENDED RELEASE COMPOSITIONS OF OPIOID ANTAGONISTS AND PHOSPHODIESTERASE 5 INHIBITORS
#1016Polyamine transport inhibitors as antivirals
#1017Diketopiperazine derivatives as calcium ATPase inhibitor for enhancing anticancer activity
#1018METHODS AND COMPOSITIONS FOR MODULATING IMMUNE DYSREGULATION
#1019METHODS AND MATERIALS FOR TREATING CALCIFIC AORTIC VALVE STENOSIS
#1020MODULATORS OF TOLL-LIKE RECEPTORS FOR THE TREATMENT OF HIV
#1021Treatment of Addiction and Impulse-Control Disorders Using PDE7 Inhibitors
#1022Self-Gelling Solutions for Administration of Therapeutics to the Inner Ear
#1023Pyridopyrazine and pyridotriazine inhibitors of influenza virus replication
#1024MODULATION OF TRF1 FOR BRAIN CANCER TREATMENT
#1025Combination therapies
#1026METHODS OF TREATING RIGHT VENTRICULAR FUNCTION IN PULMONARY HYPERTENSION
#1027Methods for the preparation of biologically active compounds in nanoparticulate form
#1028ORGANIC COMPOUNDS
#1029PDE9 INHIBITORS FOR TREATING THALASSEMIA
#1030METHODS OF TREATING RHEUMATOID ARTHRITIS, CHRONIC SPONTANEOUS URTICARIA, AND SYSTEMIC LUPUS ERYTHEMATOSIS USING AN INHIBITOR OF BRUTON'S TYROSINE KINASE
#1031SYNERGISTIC COMPOSITIONS COMPRISING R-2-(SUBSTITUTED-SULFONYL)-HEXAHYDRO-PYRROLO[1,2-A]PYRAZIN-6(2H)-ONES AND S-2-(SUBSTITUTED-SULFONYL)-HEXAHYDRO-PYRROLO[1,2-A]PYRAZIN-6(2H)-ONES IN A NON-RACEMIC RATIO
#1032METHOD AND COMPOUND FOR USE, IN TREATING AND/OR PREVENTING NETOSIS
#1033PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATING PARKINSON'S DISEASE
#1034SOLID ORAL PHARMACEUTICAL COMPOSITIONS FOR CHRONOTROPIC ADMINISTRATION OF DIPEPTIDYL PEPTIDASE IV INHIBITORS
#1035Praziquantel Formulations
#1036A COMPOSITION FOR CANCER CELL DEATH AND ITS USE
#1037SUBSTITUTED AMINO TRIAZOLOPYRIMIDINE AND AMINO TRIAZOLOPYRAZINE ADENOSINE RECEPTOR ANTAGONISTS, PHARMACEUTICAL COMPOSITIONS AND THEIR USE
#1038Solid pharmaceutical compositions comprising biopterin derivatives and uses of such compositions
#1039Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases
#1040CYCLIC PEROXIDES AS PRODRUGS FOR SELECTIVE DELIVERY OF AGENTS
#1041Compositions and methods for regulating glucose homeostasis and insulin action
#1042PDE5 inhibitor powder formulations and methods relating thereto
#1043METHODS AND TREATMENTS FOR ERECTILE DYSFUNCTION
#1044Dihydroquinoxaline and dihydropyridopyrazine derivatives as RSV inhibitors
#1045SGC stimulators
#1046NOVEL NANOPARTICLES OF ANTIRETROVIRAL DRUGS, THEIR PREPARATION AND THEIR USE FOR THE TREATMENT OF VIRAL INFECTIONS
#1047Organic compounds
#1048PHARMACEUTICAL COMPOSITION FOR TREATING DIFFUSE-TYPE GASTRIC CANCER
#1049Combination Therapy for Male Sexual Dysfunction
#1050Inhibitors of SARM1 in combination with neuro-protective agents
#1051THERAPEUTIC AGENT COMPOSITION AND METHOD OF USE, FOR TREATMENT OF MILD CONGNITIVE IMPAIRMENT, DEPRESSION, AND PSYCHOLOGICAL DISORDERS
#1052ANTIVIRAL THERAPY
#1053Methods of treating chronic lymphocytic leukemia and small lymphocytic leukemia using a BTK inhibitor
#1054Parenteral Formulations of Dopamine Agonists
#1055Liquid oral formulations for sildenafil
#1056Novel Heterocyclic Derivatives Useful as SHP2 Inhibitors
#1057SILDENAFIL FOR USE IN THE TREATMENT OF OSTEOARTHRITIS
#1058Methods of Treating Acute HCV
#1059COMPOSITIONS AND METHODS FOR SUPPRESSING MSUT2
#1060Ovarian cancer vaccines
#1061COMBINATION OF SUBSTANCES FOR REGENERATIVE THERAPY IN PATIENTS WITH TYPE 1 DIABETES MELLITUS
#1062METHODS OF TREATING CANCER WITH ARYL HYDROCARBON RECEPTOR ANTAGONISTS
#1063COMPOUNDS FOR THE TREATMENT OF MALARIA
#1064Engaging the cervical spinal cord circuitry to re-enable volitional control of hand function in tetraplegic subjects
#1065Compounds and methods
#1066Liquid oral formulations for tadalafil
#1067Uses
#1068Nonhormonal Unisex Contraceptives
#1069PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2-TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF
#1070Treatment of congenital adrenal hyperplasia
#1071Transmucosal methods for treating psychiatric and neurological conditions
#1072METHODS OF TREATING CROHN'S DISEASE AND ULCERATIVE COLITIS
#1073N-methyl-D-aspartic acid receptor modulators
#1074COMBINATION METHODS AND COMPOSITIONS INCLUDING SLEEP THERAPEUTICS FOR TREATING MOOD
#1075Pyrazole derivatives useful as 5-lipoxygenase activating protein (FLAP) inhibitors
#1076COMPOUNDS WITH HIV MATURATION INHIBITORY ACTIVITY
#1077TASTE-MASKED DOSAGE FORMS
#1078BTK Inhibitors to Treat Solid Tumors Through Modulation of the Tumor Microenvironment
#1079Fused tricyclic pyrazolo-dihydropyrazinyl-pyridone compounds as antivirals
#1080CD73 inhibitors
#1081THERAPEUTIC USE OF GLUCAGON AND COMBINATION INCLUDING THE SAME
#1082BIOACTIVE VITAMIN COMBINATIONS
#1083BRIMONIDINE COMBINATIONS AND USES THEREOF
#1084BCL-2 inhibitors
#1085BENZIMIDAZOLES THAT ENHANCE THE ACTIVITY OF OLIGONUCLEOTIDES
#1086NOVEL METHODS
#1087Fused heterotricyclic organic compounds, pharmaceutical compositions, and medical uses thereof
#1088Methods of Treating Cancers, Immune and Autoimmune Diseases, and Inflammatory Diseases Based on BTK Occupancy and BTK Resynthesis Rate
#1089COMPOSITIONS AND METHODS FOR TREATING CANCER
#1090BCL-2 inhibitors
#1091Compositions and methods
#1092Dipeptidyl peptidase-4 inhibitors for topical eye treatment of retinal neurodegenerative diseases
#1093USE OF TROP-2 AS PREDICTIVE MARKER OF RESPONSE TO ANTI-TUMOR THERAPY BASED ON INHIBITORS OF CD9, AKT AND MOLECULES OF THE TETRASPANIN SIGNALLING NETWORK
#1094Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof
#1095Treatment Regimen
#1096TARGETED PROTEIN DEGRADATION TO ATTENUATE ADOPTIVE T-CELL THERAPY ASSOCIATED ADVERSE INFLAMMATORY RESPONSES
#1097Compounds for treating or inhibiting recurrence of acute myeloid leukemia
#1098Pharmaceutical capsule compositions comprising lumateperone mono-tosylate
#1099Survivin-targeting anti-tumor agents and uses thereof
#1100Biomaterial and method for promoting tissue regeneration by using the biomaterial
#1101SUBSTITUTED BENZALDEHYDE COMPOUNDS AND METHODS FOR THEIR USE IN INCREASING TISSUE OXYGENATION
#1102Substituted indole Mcl-1 inhibitors
#1103COMBINATION THERAPY USING LOW-DOSE DOXEPIN FOR THE IMPROVEMENT OF SLEEP
#1104Use of cannabinoids in treating anti-depressant-induced female sexual dysfunction
#1105Hetero-halo inhibitors of histone deacetylase
#1106PHOSPHODIESTERASE-5 INHIBITOR COMBINATIONS, METHODS OF MAKING, AND METHODS OF USE THEREOF
#1107INTRAVAGINAL RING DEVICES
#1108COMBINATION THERAPY FOR PULMONARY HYPERTENSION
#1109LOW-DOSE TRIPLE COMBINATION FORMULATION
#1110METHODS OF USING EHMT2 INHIBITORS IN TREATING OR PREVENTING BLOOD DISORDERS
#1111ARYL ANNULATED MACROCYCLIC INDOLE DERIVATIVES
#1112ORODISPERSIBLE FILMS HAVING QUICK DISSOLUTION TIMES FOR THERAPEUTIC AND FOOD USE
#1113INCREASING IMMUNE ACTIVITY THROUGH MODULATION OF POSTCELLULAR SIGNALING FACTORS
#1114Compounds and pharmaceutical uses thereof
#1115SMALL MOLECULE IRE1-ALPHA INHIBITORS
#1116COMBINATION THERAPY FOR PI3K-ASSOCIATED DISEASE OR DISORDER
#1117Treating untreated or treatment-resistant diabetes with glucokinase activator
#1118REPEATED ADMINISTRATION OF DIHYDROERGOTAMINE FOR TREATMENT OF FREQUENT MIGRAINE HEADACHES
#1119Method of reducing pulmonary exacerbations in respiratory disease patients
#1120CD73 inhibitor and A2A/A2B adenosine receptor inhibitor combination therapy
#1121TREATMENT OF CANCER WITH COMBINATIONS OF IMMUNOREGULATORY AGENTS
#11224-IMIDAZOPYRIDAZIN-1-YL-BENZAMIDES AS BTK INHIBITORS
#1123Bromocriptine formulations
#1124TREATING SPONDYLOARTHRITIC AND PSORIATIC CONDITIONS WITH UPADACITINIB
#1125Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
#1126Methods of treating RBP4 related diseases with triazolopyridines
#1127Treatment of autism spectrum disorders, obsessive-compulsive disorder and anxiety disorders
#1128Pharmaceutical combination, composition and compound preparation containing glucokinase activator and K-ATP channel blocker, preparation method therefor and use thereof
#1129Methods
#1130Pharmaceutical combination, composition, and combination preparation comprising glucokinase activator and SGLT-2 inhibitor and preparation methods and uses thereof
#1131NOVEL COMPOUNDS AND COMPOSITIONS FOR INHIBITION OF FASN
#1132TOPICAL COMPOSITIONS FOR STIMULATING HAIR GROWTH
#1133Combinations of estrogen receptor degraders and cyclin-dependent kinase inhibitors for treating cancer
#1134Pharmaceutical combination containing glucose kinase activator and PPAR receptor activator, composition, compound preparation method for same, and uses thereof
#1135Genetic Predictors of a Response to Treatment with CRHR1 Antagonists
#1136RICTOR-TARGETED THERAPY IN THE MANAGEMENT OF BRAIN METASTASES
#1137Combination Therapy Comprising A2A/A2B and PD-1/PD-L1 Inhibitors
#1138Methods of Treating Metabolic Disease
#1139Pharmaceutical composition for the treatment of pulmonary arterial hypertension
#1140Small molecule inhibitors of cancer stem cells and mesenchymal cancer types
#1141METHODS OF TREATING COCHLEAR SYNAPTOPATHY
#1142Pharmaceutical combination and composition, and combination preparation containing glucokinase activator and biguanide hypoglycemic drug as well as preparation method and use thereof
#1143Pharmaceutical combination, composition and compound preparation comprising glucokinase activator and DPP-IV inhibitor, and preparation method and use thereof
#1144Crystal form of ACP-196 and method of treatment thereof
#1145Organic compounds
#1146Small molecule inhibitors of the nuclear translocation of androgen receptor for the treatment of castration-resistant prostate cancer
#1147METHODS OF SCHIZOPHRENIA TREATMENT
#1148CARBOXAMIDE DERIVATIVES USEFUL AS RSK INHIBITORS
#1149MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE
#1150SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS
#1151Glycosidase inhibitors
#1152Rapamycin analogs and uses thereof
#1153KRas G12C inhibitors
#1154Compositions comprising macrocycle derivatives incorporating bridged macrocycles and methods of producing and using same
#1155Bicyclic bromodomain inhibitors
#1156Therapeutic Compositions
#1157Bromocriptine formulations
#1158PAPD5 inhibitors and methods of use thereof
#1159Platform drug delivery system utilizing crystal engineering and theanine dissolution
#1160SENSITIZING CANCER TO DEATH RECEPTOR AGONISTS WITH KINASE INHIBITORS
#1161COMBINATION OF ANTI-CD20 ANTIBODY, P13 KINASE-DELTA SELECTIVE INHIBITOR, AND BTK INHIBITOR TO TREAT B-CELL PROLIFERATIVE DISORDERS
#1162Isoquinolines as inhibitors of HPK1
#1163ACTIVATION OF MITOCHONDRIAL UNCOUPLING AS A THERAPEUTIC INTERVENTION
#1164Use of sGC stimulators for the treatment of nonalcoholic steatohepatitis (NASH)
#1165Certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use therefor
#1166Substituted pyridines and methods of use
#1167ALK5 inhibitors
#1168T-cell lymphoma treatments
#1169Organic compounds
#1170COMT Inhibiting Methods and Compositions
#1171Ferroportin inhibitors
#1172Treating or preventing adverse liver conditions
#1173SOLID PHARMACEUTICAL COMPOSITIONS COMPRISING BIOPTERIN DERIVATIVES AND USES OF SUCH COMPOSITIONS
#1174Treatment of congenital adrenal hyperplasia
#1175PHARMACEUTICAL COMPOSITIONS OF SITAGLIPTIN
#1176PHARMACEUTICAL FORMULATIONS, METHOD FOR PRODUCING A PHARMACEUTICAL FORMULATION, AND MEDICAMENT COMPRISING SAME
#1177Composition and method for treating metabolic disorders
#1178METHOD FOR TREATING CARDIOPULMONARY DISORDER
#1179Treatment for Wolfram syndrome and other endoplasmic reticulum stress disorders
#1180COMBINATION COMPOSITIONS FOR IMMUNOTHERAPY
#1181Substituted fused heteroaromatic tricyclic compounds as kinase inhibitors and the use thereof
#1182COMPOSITIONS AND METHODS FOR TREATING HEMORRHAGIC STROKE
#1183Bruton's tyrosine kinase inhibitors
#1184Fused heterocyclic compound
#1185TRICYCLIC HETEROCYCLE COMPOUNDS USEFUL AS HIV INTEGRASE INHIBITORS
#1186PREVENTIVE AND/OR THERAPEUTIC AGENT FOR AUTOIMMUNE DISEASE COMPRISING COMPOUND HAVING Btk INHIBITORY ACTIVITY AS ACTIVE INGREDIENT
#1187SUBSTITUTED TETRAHYDROQUINOLINONE COMPOUNDS AS ROR GAMMA MODULATORS
#1188Treatment of idiopathic pulmonary fibrosis
#1189METHOD OF TREATING EPILEPSY OR EPILEPTIC ENCEPHALOPATHY WITH FENFLURAMINE IN PATIENTS WITHOUT PULMONARY HYPERTENSION
#1190Pharmaceutical compounds
#1191Bruton's tyrosine kinase inhibitors
#1192Treatment of erectile dysfunction and other indications
#1193Pharmaceutical composition for stimulating stem cell division and suppressing bacterial virulence
#1194Diacylglycerol acyl transferase 2 inhibitor
#1195Diacylglycerol acyl transferase 2 inhibitor
#1196Inhibitors of receptor interacting protein kinase I for the treatment of disease
#1197Composition and method for treating metabolic disorders
#1198Inhibitors of receptor interacting protein kinase I for the treatment of disease
#1199Methods
#1200TREATMENT FOR DIABETES IN PATIENTS INAPPROPRIATE FOR METFORMIN THERAPY